Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boulin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Clinical Pharmacy and Therapeutics|April 14, 2015
A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 yearsA-S Lang, M Mounier, M Roques, et al.
Diagnostic and Interventional Imaging|May 23, 2015
Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the dayM Boulin, E Delhom, M-A Pierredon-Foulongne, et al.
Therapie|April 2, 2003
[Thalidomide with or without dexamethasone for refractory multiple myeloma]M Boulin, F Blanchet, N Isambert, et al.
Diagnostic and Interventional Imaging|November 14, 2012
Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patientsL Vadot, M Boulin, C Malbranche, et al.
Annales Pharmaceutiques Francaises|May 11, 2016
Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignanciesM-A Opsomer, A Anota, M Noblot-Rossignol, et al.
Journal of Clinical Pharmacy and Therapeutics|November 22, 2014
Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinomaL Vadot, M Boulin, B Guiu, et al.
Annales Pharmaceutiques Francaises|May 1, 2014
Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemiaA Monnier, C Malbranche, P Fagnoni, et al.
Leukemia|September 24, 2013
RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cellsA Chanut, F Duguet, A Marfak, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Clinical Pharmacy and Therapeutics|April 14, 2015
A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 yearsA-S Lang, M Mounier, M Roques, et al.
Diagnostic and Interventional Imaging|May 23, 2015
Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the dayM Boulin, E Delhom, M-A Pierredon-Foulongne, et al.
Therapie|April 2, 2003
[Thalidomide with or without dexamethasone for refractory multiple myeloma]M Boulin, F Blanchet, N Isambert, et al.
Diagnostic and Interventional Imaging|November 14, 2012
Result and cost of hepatic chemoembolisation with drug eluting beads in 21 patientsL Vadot, M Boulin, C Malbranche, et al.
Annales Pharmaceutiques Francaises|May 11, 2016
Impact of pharmaceutical intervention on quality of life and coping strategies in patients with haematological malignanciesM-A Opsomer, A Anota, M Noblot-Rossignol, et al.
Journal of Clinical Pharmacy and Therapeutics|November 22, 2014
Clinical and economic impact of drug eluting beads in transarterial chemoembolization for hepatocellular carcinomaL Vadot, M Boulin, B Guiu, et al.
Annales Pharmaceutiques Francaises|May 1, 2014
Generic vancomycin products: Analysis of serum concentrations in patients with acute myeloid leukemiaA Monnier, C Malbranche, P Fagnoni, et al.
Leukemia|September 24, 2013
RelA and RelB cross-talk and function in Epstein-Barr virus transformed B cellsA Chanut, F Duguet, A Marfak, et al.
Alimentary Pharmacology & Therapeutics|April 18, 2014
Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trialM Boulin, P Hillon, J P Cercueil, et al.
Pageof 1